Chronic morphine administration produced a larger increase in neuronal CB2 receptor expression in the spinal dorsal horn than peripheral nerve injury alone, suggesting CB2-opioid receptor interactions may contribute to combined cannabinoid-opioid treatment effects.
Pain researchers, opioid pharmacologists, cannabinoid-opioid combination therapy investigators
Morphine produced larger CB2 upregulation than peripheral nerve injury
What the researchers found
CB2 receptors were predominantly expressed on neurons (NeuN-labeled cells) rather than microglia in the spinal dorsal horn. Chronic morphine administration (10 days) significantly increased CB2 receptor labeling across all surgery groups in both deep and superficial dorsal horn regions. Morphine produced a larger CB2 upregulation than surgery alone.
Why it matters
The synergistic pain-relieving effects of opioids and cannabinoids are well-documented but poorly understood. This finding that morphine upregulates neuronal CB2 receptors suggests a mechanism through which opioids may prime the system for cannabinoid-mediated pain relief.
The numbers in context
24 rats; 3 surgery groups x 2 drug conditions; CB2 predominantly on NeuN+ neurons; morphine significantly increased CB2 in deep and superficial dorsal horn; morphine effect larger than CCI surgery effect
How the study worked
24 male Sprague Dawley rats assigned to chronic constriction injury (CCI), sham surgery, or pain-naive groups, with half receiving daily morphine (5 mg/kg) for 10 days. Fluorescent immunohistochemistry on spinal cord sections assessed CB2 colocalization with neuronal (NeuN) and microglial (CD11b) markers.
What this study cannot tell us
Male rats only. Immunohistochemistry provides expression data but not functional receptor activity. Single morphine dose and duration tested. Does not prove the CB2 upregulation translates to enhanced cannabinoid analgesia.
How to read the evidence
Novel mechanistic finding with rigorous histological methods, but limited by male-only design and lack of functional behavioral validation.
When this study was published
Published in 2021.
The bigger picture
If morphine increases CB2 receptor availability, then adding cannabinoid treatment during or after opioid therapy could provide enhanced pain relief. This has implications for opioid-sparing strategies using combination cannabinoid-opioid approaches.
Questions still open
- Does the morphine-induced CB2 upregulation enhance responses to cannabinoid pain medications? Could this mechanism be leveraged to reduce opioid doses through cannabinoid co-administration?
Common questions
What does this mean for combining opioids and cannabinoids?
Were CB2 receptors on neurons or immune cells?
Read the original research
Morphine Induces Upregulation of Neuronally Expressed CB2 Receptors in the Spinal Dorsal Horn of Rats.
Cannabis and cannabinoid research, 6(2), 137-147
Citation
Grenier, Patrick; Sunavsky, Adam; Olmstead, Mary C. (2021). Morphine Induces Upregulation of Neuronally Expressed CB2 Receptors in the Spinal Dorsal Horn of Rats.. Cannabis and cannabinoid research, 6(2), 137-147. https://doi.org/10.1089/can.2020.0004
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk